The glycolytic inhibitor 2-deoxy-D-glucose (2-DG), a potent therapeutic adjuvant in cancer radiotherapy, was tested for the reversibility of its inhibitory action on X-ray-induced DNA double strand break (dsb) repair. Cells were exposed to 40 Gy of X-rays and allowed to repair with or without 2-DG in suspension at 37 degrees C. DNA dsb rejoining was measured by pulsed field gel electrophoresis. The fraction of 14C-thymidine activity released from the plug (FAR) during electrophoresis was used as a measure for the number of dsb present in the DNA. After certain time intervals 2-DG was withdrawn from the cells and the extent of reversal of inhibition of dsb rejoining was measured. Biphasic repair of dsb was generally observed, with a fast component extending up to about 60 min after irradiation and a much slower progression of repair thereafter. Different mathematical models are considered for a quantitative description of these two components. The experimental data strongly indicate that only one type of dsb is primarily induced by irradiation which can be repaired fast with a time constant of about 0.05 min-1 (t1/2 approximately 13 min). In competition with this repair, other DNA dsb arise which are repaired slowly with a time constant of about 0.009 min-1 (t1/2 approximately 77 min). The time constant for the transformation of fast reparable dsb into slowly repaired dsb is about 0.026 min-1. Treatment with 2-DG inhibits the fast repair and, as a consequence, more DNA dsb are transformed into the type being repaired slowly. In competition with this slow repair, DNA dsb are fixed. Treatment with 2-DG also reduces slow repair processes and as a consequence the number of lesions being fixed is increased. Cell survival and ATP content of the cells showed a reversibility to the same extent as dsb repair, indicating the close relationship of these processes in living cells.
No takes yet. Share an insight, caveat, or question.
Jha et al. (1993) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: